-
The Use of Large Language Models for Systematic Literature Review Automation: An Evaluation of Quality and Time Savings
Mar 10, 2025, 14:00 PM -
Trial-Based Economic Evaluation of 'Partner in Balance,' a Blended Self-management Program for Early-Stage Dementia Caregivers in the Netherlands: The Health-Economic Analysis Plan and Baseline Results
Mar 10, 2025, 14:00 PM -
Cost Effectiveness Analysis of Lanadelumab vs C1 Inhibitor for Long-Term Prophylaxis of Hereditary Angioedema: A Brazilian Private Sector Perspective
Mar 10, 2025, 14:00 PM -
Differences in Demographic and Clinical Profiles Among Patients Adherent Vs. Non-Adherent to Revefenacin Following a COPD-Related Hospitalization
Mar 10, 2025, 14:00 PM -
A Real-World Analysis of Patient Cost Burden From COPD and Its Treatment Regimens
Mar 10, 2025, 14:00 PM -
Budget Impact Model of Enhanced Lung Cancer Screening With AI/ML Tech-Based Software as a Medical Device (SaMD) on a US Cohort and Private Payer Perspective
Mar 10, 2025, 14:00 PM -
Healthcare Resource Use in Commercially- and Medicaid-Insured Infants, Toddlers, and Children Diagnosed With Invasive Meningococcal Disease in the United States
Mar 10, 2025, 14:00 PM -
Early Germline BRCA Testing in Breast Cancer: A Review of Value Frameworks and Cost-Effectiveness Analyses
Mar 10, 2025, 14:00 PM -
Assessing Disease Severity: How HTA Bodiea Evaluate Unmet Needs and Influemce Decision-Making
Mar 10, 2025, 14:00 PM -
Real-World Effectiveness of Biologic Treatments for Moderate-to-Severe Plaque Psoriasis in Poland in Comparison With Efficacy Reported in Clinical Trials
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness Analysis of Lenvatinib vs Key Comparators in First-Line Unresectable Hepatocellular Carcinoma in Canada
Mar 10, 2025, 14:00 PM -
Preferences for Parkinson's Disease Treatments: A Scoping Literature Review
Mar 10, 2025, 14:00 PM -
Access and Quality of Usual Source of Care and Racial/Ethnic Disparities in US Adults with Multiple Chronic Conditions
Mar 10, 2025, 14:00 PM -
The Prevalence of Fractional-Polynomial Network Meta-analyses (fpNMAs) in Supporting Reimbursement Recommendations by Canada's Drug Agency (CDA-AMC)
Mar 10, 2025, 14:00 PM -
Exploring Patient Preferences for Systemic Treatments in Psoriasis: A Review of the Literature
Mar 10, 2025, 14:00 PM -
Trends in the Global Drug Development Pipeline 2024
Mar 10, 2025, 14:00 PM -
Meaningful Changes in Physical Function and Pain in Patients with K-L Grade 3 Knee Osteoarthritis
Mar 10, 2025, 14:00 PM -
Patient, Caregiver, and Physician Perspectives on the Burden of Disease Chronic Refractory Gout and Its Treatment: Concept Elicitation
Mar 10, 2025, 14:00 PM -
Physician-Reported Satisfaction with, Challenges in, and Patient Adherence to, Immunosuppressive Treatment among Kidney Transplant Recipients: Results From a Real-World Survey
Mar 10, 2025, 14:00 PM -
Impact of Capacity and Resource Constraints on Wet Age-Related Macular Degeneration and Diabetic Macular Edema in the Brazilian Public Healthcare System: an Individual-Level Microsimulation Study
Mar 10, 2025, 14:00 PM
